Please login to the form below

Not currently logged in
Email:
Password:

S-A acquires rights to diabetes technology

Sanofi-aventis has acquired the global rights to a diabetes drug-delivery technology from Ascendis Pharma

Sanofi-aventis (S-A) has acquired the global rights to a diabetes drug-delivery technology from Ascendis Pharma.

S-A will receive a worldwide licence to develop, manufacture and commercialise products that use Ascendis' TransCon Linker and Hydrogel carrier technology to develop treatments for diabetes and related disorders.

In return, Ascendis will receive an undisclosed upfront payment, as well as potential development, regulatory and commercial milestones.

The technology uses TransCon Linker families – structures with self-cleaving properties – which enable drug release in the body to be independent of enzyme activity and tissue condition.

These structures can form transient bonds with larger molecules such as proteins, including insulin, allowing them to be used as carriers in drug delivery.

This enables drug compounds to be released into the body for precise periods at specified times, creating a more long-acting effect.

"We are excited about this promising technology to create next-generation products in the field of diabetes and related disorders," said Pierre Chancel, senior vice president, head of the Global Diabetes Division, S-A. "Building on our achievements with Lantus, our 24-hour insulin approved for use once a day, we hope to further improve the lives of people with diabetes by developing this innovative technology to offer biologicals that present an extended and controlled release of unmodified parent drugs, including insulin."

This is the second major diabetes related deal made this week following Novo Nordisk's licence agreement with Emisphere Technologies to develop and market oral insulins.

The two companies will use Emisphere's Eligen technology to allow small and large molecule drugs to be taken orally without their chemical form being altered by processes in the body.

21st December 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

Medical information in precision medicine
Global Medical Information Leader James Oughton reveals the top trends in medical information and precision medicine....
Australian Flu and the dilemma of naming diseases
...
Wearables and Healthcare
What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...

Infographics